4-(Dibromomethyl)-3-methoxybenzonitrile, 95.0%, 250mg

(11bS)-4-Hydroxy-2,6-bis(2,3,4,5,6-pentafluorophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 99.93%, 100mg

Methyl 4-oxochroman-7-carboxylate, 95.0%, 1g

3-(4-Ethoxy-3-methylphenyl)-1-phenyl-1H-pyrazole-4-carbaldehyde, 98%, 100mg

Vinyl Terminated Polydimethylsiloxane, cSt20,000, 3kg

(S)-2-Amino-2-(2-bromo-4-fluorophenyl)acetic acid hydrochloride, 98%, 1g

6-Bromo-2-(bromomethyl)-3-fluoropyridine, 96%, 1g

Decylbenzene>98.0%(GC)25mL

trans-4-Isopropylcyclohexanecarboxylic Acid>98.0%(GC)(T)25g

5-Chloropyrazolo[1,5-a]pyrimidine-3-carbaldehyde, 97%, 500mg

1-(4-Fluorobenzyl)-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 5g

Ethyl 4-chlorothieno[3,2-d]pyrimidine-2-carboxylate, 95.0%, 1g

N-(Cyclohexylmethyl)cyclopropanamine, 95.0%, 10g